PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of General Internal and Emergency Medicine and Department of Endocrinology, Diabetology and Metabolism, Medical University Clinic, Aarau, Switzerland.\', \'Endocrinology, Diabetology and Metabolism, Department of Internal Medicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.\', \'Stoffwechselzentrum, Solothurn, Switzerland.\', \'Clinical Trial Unit, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.\', \'Institute of Primary Health Care (BIHAM), University of Bern, Switzerland.\', \'Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.\', \'Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.\', \'Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jcph.1914
?:hasPublicationType
?:journal
  • Journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34031890
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.997
?:rankingScore_hIndex
  • 104
is ?:relation_isRelatedTo_publication of
?:title
  • Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all